COVID-19 VOICE STUDY

Use Voice to Fight COVID-19

We are launching an initiative to collect your voices with a goal to be able to triage, screen and monitor COVID-19 virus.

Donate your voice to help those suffering from COVID-19 and rapidly build a point-of-care diagnostic to save lives. 

free css templates

About the Study

We believe that by analyzing the voice beyond what the human ear can hear, we can unveil dedicated vocal biomarkers that will enable the healthcare community to get insights on the symptoms and hopefully the onset of the COVID-19 virus.

We are deploying a state-of-the-art Artificial Intelligence method and technique to correlate the voice with the symptoms of the COVID-19. This will enable an alert about early symptoms and monitoring at home by only using a smart phone.
The study is being conducted under IRB approval, as required for clinical research.

Join us now and to fight COVID-19 by leveraging your own voice.

Voice Donor FAQ

By being a voice donor, you'll accelerate the pace of COVID-19 diagnostic research and help save lives during this crisis.

Because it can help Humanity.

The COVID-19 viral disease that has swept into at least 114 countries and killed more than 4,000 people is now officially a pandemic according to the World Health Organization.

We believe that by analyzing the voice beyond what the human ear can hear we can unveil dedicated vocal biomarkers that will enable the healthcare community to get insights on the symptoms and helpfully the onset of the COVID-19 virus.

We are deploying a state-of-the-art Artificial Intelligence method and technique to correlate the voice with the symptoms of the COVID-19. This will enable to provide an alert on early symptoms and monitor at home by only using a smart phone.

The time is now to do research studies to diagnose COVID-19 suffers to help triage care and save lives. Join us now and to fight COVID-19 by leveraging your own voice. 

Your personal health information will be handled securely. All data collected on our servers is encrypted end-to-end. We will anonymize the data and use it with the intention to conduct research and translate this work to patients.

We have structured the trial as a 4 week longitudinal study and we estimated it will take roughly 15-20 minutes of your time. You can record voice samples and take part of this study for as long as you want by downloading and using our iPhone application.

The first week is the most time-intensive, where we will ask a 10 minute inventory and collect voice data from a few tasks in series.

During the second, third, and fourth weeks, we will just follow up with a few short survey questions and some voice samples, each taking 2-3 minutes each.

You can use any laptop, tablet, or mobile phone to complete this study. The only strict requirement is that you have a stable internet connection to submit voice samples.

In general, the best way to provide a voice sample is in a quiet room where you are speaking close to the microphone. If this is possible, please take the survey in a quiet room. Otherwise, your voice sample may be contaminated and discarded from scientific analysis.

You can find the consent form for the COVID-19 Voice Study here.

Mobirise

Spread the word

Help us spread the word and recruit more patients into the COVID-19 study by retweeting our link on Twitter.

Clinical Study FAQ

We are collaborating with the world's leading research institutions, nonprofits, medical device companies, and pharmaceutical companies to recruit patients into the COVID-19 Voice Study.

Our goal is to enroll at least 100,000 patients to collect as much data as possible with voice information tied to COVID-19 symptoms.

March 15th, 2020 - December 30th, 2020.

Since the study lasts at least one month long for patients, the last day to enroll in the study is December 1st, 2020.

The study is designed to be longitudinal to take a voice sample at baseline and track patients week-over-week (WoW) for 1 month. We recommend downloading the app to provide additional data on a daily basis.

We're seeking collaborations with individuals, nonprofits, academic facilities, pharma/medical device companies, and private donors to advance this initiative.

For Individuals - You can donate your voice as a part of this study at this link. Anyone can partake in the study, we just ask that you answer all questions honestly and to the best of your ability.

For Nonprofits and Academic Facilities - You can send out the link to enroll in the clinical study as a part of a mailing list or embed snippets to be recruited on their website. We have many of these links and descriptions already made to make this step very easy for you.

For Corporation/ Companies - If you are a company looking to help us in our effort to provide solution to COVID-19 or collect voice data as a part of your clinical trials, we encourage you approach us by filling out the contact form at the bottom of this web page.

For Private Donors - If you're interested to personally support our work through a foundation or another vehicle, please reach out to us. We've thought about how we can make this happen through nonprofit collaborators.

If you're interested in any of these areas or have other ways to work together, just reach out to us on the webform at the bottom of this page and we'll get back to you promptly.

To take part of the study you must be a healthy adult (>18 years of age) that can produce speech vocalizations in English. If you do not fit this criteria, you cannot participate in the study.

Mobirise

Our Team

We have a strong team of scientists, engineers, computer scientists, and health professionals to ethically translate this work to patients. 

COVID-19 FAQ

We aim to create the largest dataset in the world of voice data tied to COVID-19 symptoms and publish our work openly in peer-reviewed journals. 

This virus was first detected in Wuhan City, Hubei Province, China. The first infections were linked to a live animal market, but the virus is now spreading from person-to-person. It’s important to note that person-to-person spread can happen on a continuum. Some viruses are highly contagious (like measles), while other viruses are less so.

The virus that causes COVID-19 seems to be spreading easily and sustainably in the community (“community spread”) in some affected geographic areas. Community spread means people have been infected with the virus in an area, including some who are not sure how or where they became infected.

This is a rapidly evolving situation and the risk assessment may change daily. The latest updates are available on CDC’s Coronavirus Disease 2019 (COVID-19) website.

The following information is for information purposes only, please refer to CDC or healthcare professional for the latest information.

According to the CDC, reported illnesses have ranged from mild symptoms to severe illness and death for confirmed coronavirus disease 2019 (COVID-19) cases.

The following symptoms may appear 2-14 days after exposure.*

- Fever
- Cough
- Shortness of breath


We believe many of these symptoms can be logged through voice tasks like phonation ('ahhh') and free speech (e.g. 'describe your day from start to finish') - and could potentially be used to screen for COVID-19 symptoms early. 

If you develop symptoms such as fever, cough, and/or difficulty breathing, and have been in close contact with a person known to have COVID-19 or have recently traveled from an area with ongoing spread of COVID-19, we recommend approaching a healthcare professional to determine whether you should be tested for COVID-19.

The virus that causes COVID-19 is spreading from person-to-person. Someone who is actively sick with COVID-19 can spread the illness to others. That is why CDC recommends that these patients be isolated either in the hospital or at home (depending on how sick they are) until they are better and no longer pose a risk of infecting others.

How long someone is actively sick can vary so the decision on when to release someone from isolation is made on a case-by-case basis in consultation with doctors, infection prevention and control experts, and public health officials and involves considering specifics of each situation including disease severity, illness signs and symptoms, and results of laboratory testing for that patient.

Current CDC guidance for when it is OK to release someone from isolation is made on a case by case basis and includes meeting all of the following requirements:

- The patient is free from fever without the use of fever-reducing medications.
- The patient is no longer showing symptoms, including cough.
- The patient has tested negative on at least two consecutive respiratory specimens collected at least 24 hours apart.

Someone who has been released from isolation is not considered to pose a risk of infection to others.

Please refer to CDC website for additional information and recommendations.

For recommendations and guidance on persons under investigation; infection control, including personal protective equipment guidance; home care and isolation; and case investigation, see Information for Healthcare Professionals. For information on specimen collection and shipment, see Information for Laboratories. For information for public health professional on COVID-19, see Information for Public Health Professionals.

Mobirise

Contact Us

We're excited to hear from you.

© Copyright 2020 COVID-19 Voice Study
Terms of Use
Privacy Policy